Cargando…

Effectiveness of Sublingual Buprenorphine and Fentanyl Pump in Controlling Pain After Open Cholecystectomy

BACKGROUND: The proper management of postoperative pain improves patients’ quality of life, accelerates early postoperative recovery, shortens hospitalization period, and reduces medical costs. This study aimed to compare the effectiveness of intravenous fentanyl pump and sublingual buprenorphine ta...

Descripción completa

Detalles Bibliográficos
Autores principales: Norozi, Vadood, Ghazi, Ahmad, Amani, Firouz, Bakhshpoori, Parya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kowsar 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438705/
https://www.ncbi.nlm.nih.gov/pubmed/34540635
http://dx.doi.org/10.5812/aapm.113909
_version_ 1783752399908765696
author Norozi, Vadood
Ghazi, Ahmad
Amani, Firouz
Bakhshpoori, Parya
author_facet Norozi, Vadood
Ghazi, Ahmad
Amani, Firouz
Bakhshpoori, Parya
author_sort Norozi, Vadood
collection PubMed
description BACKGROUND: The proper management of postoperative pain improves patients’ quality of life, accelerates early postoperative recovery, shortens hospitalization period, and reduces medical costs. This study aimed to compare the effectiveness of intravenous fentanyl pump and sublingual buprenorphine tablet in controlling pain after open cholecystectomy. OBJECTIVES: Evaluating the effectiveness of sublingual buprenorphine in reducing postoperative pain and complications after open cholecystectomy. METHODS: This study was a double-blind, randomized clinical trial. The study population encompassed those candidates undergoing open cholecystectomy, patients with ASA class I and II, individuals undergoing no other concomitant surgery, and patients in the age range of 20 - 50 years. The first group received sublingual buprenorphine 6, 12, and 18 hours after the first administration. The second group received fentanyl as patient-controlled analgesia (PCA) for 24 hours. Then nausea, vomiting, sedation, and Visual Analog Scale (VAS) scores were evaluated at the beginning, 2, 6, 12, 18, and 24 hours after surgery. The collected data were analyzed using SPSS software version 20. RESULTS: The mean age of the patients in the buprenorphine and fentanyl groups were 44.8 ± 5.5 and 42.8 ± 7.1 years, respectively. In this study, 22.5% of the patients in the buprenorphine group and 35.5% of the patients in the fentanyl group were male. During 6 and 24 hours after surgery, the pain level regarding the VAS scores was significantly lower in the buprenorphine group than in the fentanyl group; however, analgesic consumption was higher in the fentanyl group. In the early hours after surgery (2 and 6 hours), nausea and vomiting were lower in the buprenorphine group than in the fentanyl group even though the difference was not significant. CONCLUSIONS: This study suggests buprenorphine as an effective drug for patients to reduce postoperative pain because of its limited complications, inexpensiveness, and more convenient administration method.
format Online
Article
Text
id pubmed-8438705
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Kowsar
record_format MEDLINE/PubMed
spelling pubmed-84387052021-09-17 Effectiveness of Sublingual Buprenorphine and Fentanyl Pump in Controlling Pain After Open Cholecystectomy Norozi, Vadood Ghazi, Ahmad Amani, Firouz Bakhshpoori, Parya Anesth Pain Med Research Article BACKGROUND: The proper management of postoperative pain improves patients’ quality of life, accelerates early postoperative recovery, shortens hospitalization period, and reduces medical costs. This study aimed to compare the effectiveness of intravenous fentanyl pump and sublingual buprenorphine tablet in controlling pain after open cholecystectomy. OBJECTIVES: Evaluating the effectiveness of sublingual buprenorphine in reducing postoperative pain and complications after open cholecystectomy. METHODS: This study was a double-blind, randomized clinical trial. The study population encompassed those candidates undergoing open cholecystectomy, patients with ASA class I and II, individuals undergoing no other concomitant surgery, and patients in the age range of 20 - 50 years. The first group received sublingual buprenorphine 6, 12, and 18 hours after the first administration. The second group received fentanyl as patient-controlled analgesia (PCA) for 24 hours. Then nausea, vomiting, sedation, and Visual Analog Scale (VAS) scores were evaluated at the beginning, 2, 6, 12, 18, and 24 hours after surgery. The collected data were analyzed using SPSS software version 20. RESULTS: The mean age of the patients in the buprenorphine and fentanyl groups were 44.8 ± 5.5 and 42.8 ± 7.1 years, respectively. In this study, 22.5% of the patients in the buprenorphine group and 35.5% of the patients in the fentanyl group were male. During 6 and 24 hours after surgery, the pain level regarding the VAS scores was significantly lower in the buprenorphine group than in the fentanyl group; however, analgesic consumption was higher in the fentanyl group. In the early hours after surgery (2 and 6 hours), nausea and vomiting were lower in the buprenorphine group than in the fentanyl group even though the difference was not significant. CONCLUSIONS: This study suggests buprenorphine as an effective drug for patients to reduce postoperative pain because of its limited complications, inexpensiveness, and more convenient administration method. Kowsar 2021-08-08 /pmc/articles/PMC8438705/ /pubmed/34540635 http://dx.doi.org/10.5812/aapm.113909 Text en Copyright © 2021, Author(s) https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
spellingShingle Research Article
Norozi, Vadood
Ghazi, Ahmad
Amani, Firouz
Bakhshpoori, Parya
Effectiveness of Sublingual Buprenorphine and Fentanyl Pump in Controlling Pain After Open Cholecystectomy
title Effectiveness of Sublingual Buprenorphine and Fentanyl Pump in Controlling Pain After Open Cholecystectomy
title_full Effectiveness of Sublingual Buprenorphine and Fentanyl Pump in Controlling Pain After Open Cholecystectomy
title_fullStr Effectiveness of Sublingual Buprenorphine and Fentanyl Pump in Controlling Pain After Open Cholecystectomy
title_full_unstemmed Effectiveness of Sublingual Buprenorphine and Fentanyl Pump in Controlling Pain After Open Cholecystectomy
title_short Effectiveness of Sublingual Buprenorphine and Fentanyl Pump in Controlling Pain After Open Cholecystectomy
title_sort effectiveness of sublingual buprenorphine and fentanyl pump in controlling pain after open cholecystectomy
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438705/
https://www.ncbi.nlm.nih.gov/pubmed/34540635
http://dx.doi.org/10.5812/aapm.113909
work_keys_str_mv AT norozivadood effectivenessofsublingualbuprenorphineandfentanylpumpincontrollingpainafteropencholecystectomy
AT ghaziahmad effectivenessofsublingualbuprenorphineandfentanylpumpincontrollingpainafteropencholecystectomy
AT amanifirouz effectivenessofsublingualbuprenorphineandfentanylpumpincontrollingpainafteropencholecystectomy
AT bakhshpooriparya effectivenessofsublingualbuprenorphineandfentanylpumpincontrollingpainafteropencholecystectomy